Form 4: OptimizeRx COO Merrell Reports Routine Stock Disposition

OptimizeRx Chief Operating Officer Brendan W. Merrell reported the disposition of 289 shares of common stock to cover tax withholding obligations related to restricted stock unit vesting.

Summary

• Brendan W. Merrell, Chief Operating Officer of OptimizeRx Corp (OPRX), reported a transaction on December 19, 2025.
• 289 shares of OptimizeRx Common Stock were disposed of at a price of $13.51 per share.
• This disposition was a withholding by the Issuer to satisfy tax obligations upon the vesting of restricted stock units.
• Following this transaction, Merrell beneficially owns 26,207 shares of OptimizeRx Common Stock directly.

Sentiment

Score: 5

Explanation: The filing reports a routine insider transaction for tax withholding purposes, which is neutral in sentiment and a standard part of executive compensation.

Future Outlook

N/A

Industry Context

This is a routine insider transaction related to compensation and tax obligations, which is common across all publicly traded companies and does not reflect specific industry trends for healthcare technology.

Related Party Transactions

• The disposition of 289 shares of common stock to the Issuer (OptimizeRx Corp) to satisfy tax withholding obligations upon the vesting of restricted stock units.

Stakeholder Impact

• Minimal impact on shareholders as this is a routine, non-discretionary transaction related to executive compensation.
• No direct impact on employees, customers, suppliers, or creditors.

Key Dates

Keywords

OptimizeRx, OPRX, Brendan Merrell, Insider Transaction, Form 4, Stock Disposition, Tax Withholding, Restricted Stock Units, Officer